Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.700
+0.010 (0.59%)
At close: Aug 12, 2026, 4:00 PM EDT
1.710
+0.010 (0.59%)
After-hours: Aug 12, 2026, 4:02 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $168.61 million as of August 12, 2026. Its market cap has increased by 6.02% in one year.
Market Cap
168.61M
Enterprise Value
76.93M
1-Year Change
6.02%
Ranking
Category
Stock Price
$1.70
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $168.61M, a decrease of -81.02%. That is a compound annual growth rate of -28.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 168.61M | 13.45% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 179.12M |
| Codexis | 173.71M |
| Humacyte | 172.57M |
| Tenaya Therapeutics | 172.11M |
| Nkarta | 169.75M |
| OnKure Therapeutics | 163.61M |
| Kazia Therapeutics | 159.98M |
| Milestone Pharmaceuticals | 156.46M |